More potent than its predecessors, retatrutide activates three receptorsGLP-1, GIP, and glucagonas opposed to only one (as is the case with semaglutide) or two (like tirzepatide)
The cardiovascular outcome data for Tirzepatide will likely be positive given the metabolic improvements observed
In my experience reviewing the GLP-1 literature, a 5% threshold response rate near 100% is unusual
The peptides mechanism involves: Pancreatic Beta-Cell Modulation : Activation of both GIPR and GLP-1R enhances glucose-dependent insulin secretion from pancreatic -cells through distinct but complementary signaling pathways
Comparative Growth Hormone Fragment Studies : Comparing AOD 9604 with full-length human growth hormone and other C-terminal fragments to better understand which regions of the hormone drive specific metabolic effects and which pathways operate independently of classical GH receptor signaling
Video: For the simplest explanation of how these 2 amazing ingredients work, check out our video above